Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter and slashed its full-year adjusted profit guidance, sending its stock tumbling roughly 10%. The drugmaker now expects full-year adjusted earnings of between $13….